215 related articles for article (PubMed ID: 21133701)
1. Applications of 'decisionable' biomarkers in cardiovascular drug development.
Krishna R; Wagner JA
Biomark Med; 2010 Dec; 4(6):815-27. PubMed ID: 21133701
[TBL] [Abstract][Full Text] [Related]
2. Innovations driving biomarker evaluation and use.
Wagner JA
Biomark Med; 2010 Dec; 4(6):779-81. PubMed ID: 21133694
[No Abstract] [Full Text] [Related]
3. The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development.
Soares HD
Curr Opin Investig Drugs; 2010 Jul; 11(7):795-801. PubMed ID: 20571975
[TBL] [Abstract][Full Text] [Related]
4. The role of molecular imaging in drug discovery and development.
Hargreaves RJ
Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
[TBL] [Abstract][Full Text] [Related]
5. From biomarker strategies to biomarker activities and back.
van Gool AJ; Henry B; Sprengers ED
Drug Discov Today; 2010 Feb; 15(3-4):121-6. PubMed ID: 19931413
[TBL] [Abstract][Full Text] [Related]
6. Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development.
Kearns GL
Biomark Med; 2010 Dec; 4(6):783-6. PubMed ID: 21133695
[No Abstract] [Full Text] [Related]
7. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
8. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic biomarkers for molecular cancer therapeutics.
Sarker D; Workman P
Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
[TBL] [Abstract][Full Text] [Related]
10. A multistep validation process of biomarkers for preclinical drug development.
Freeman WM; Bixler GV; Brucklacher RM; Lin CM; Patel KM; VanGuilder HD; LaNoue KF; Kimball SR; Barber AJ; Antonetti DA; Gardner TW; Bronson SK
Pharmacogenomics J; 2010 Oct; 10(5):385-95. PubMed ID: 19997081
[TBL] [Abstract][Full Text] [Related]
11. The quest for biomarkers in tuberculosis.
Parida SK; Kaufmann SH
Drug Discov Today; 2010 Feb; 15(3-4):148-57. PubMed ID: 19854295
[TBL] [Abstract][Full Text] [Related]
12. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease.
Puntmann VO
Postgrad Med J; 2009 Oct; 85(1008):538-45. PubMed ID: 19789193
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive structural, functional, and molecular imaging in drug development.
Rudin M
Curr Opin Chem Biol; 2009 Jun; 13(3):360-71. PubMed ID: 19447067
[TBL] [Abstract][Full Text] [Related]
14. A guidance for renal biomarker lead optimization and use in translational pharmacodynamics.
Ozer JS
Drug Discov Today; 2010 Feb; 15(3-4):142-7. PubMed ID: 20026239
[TBL] [Abstract][Full Text] [Related]
15. Safety biomarkers in preclinical development: translational potential.
Sasseville VG; Mansfield KG; Brees DJ
Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
[TBL] [Abstract][Full Text] [Related]
16. Use of biomarkers in the discovery of novel anti-schizophrenia drugs.
Mikkelsen JD; Thomsen MS; Hansen HH; Lichota J
Drug Discov Today; 2010 Feb; 15(3-4):137-41. PubMed ID: 20036755
[TBL] [Abstract][Full Text] [Related]
17. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular pharmacology in the post-blockbuster era.
Brandes RP
Curr Opin Pharmacol; 2010 Apr; 10(2):109-10. PubMed ID: 20202904
[No Abstract] [Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in clinical drug development.
Gobburu JV
Clin Pharmacol Ther; 2009 Jul; 86(1):26-7. PubMed ID: 19536121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
